Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H25N3 |
Molecular Weight | 331.454 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC1=NN=C(C2=CC=CC=C2)C3=C1C=CC=C3)C4CCCCC4
InChI
InChIKey=OJBBUQUNTTVULM-MRXNPFEDSA-N
InChI=1S/C22H25N3/c1-16(17-10-4-2-5-11-17)23-22-20-15-9-8-14-19(20)21(24-25-22)18-12-6-3-7-13-18/h3,6-9,12-17H,2,4-5,10-11H2,1H3,(H,23,25)/t16-/m1/s1
Molecular Formula | C22H25N3 |
Molecular Weight | 331.454 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:04:07 UTC 2023
by
admin
on
Sat Dec 16 18:04:07 UTC 2023
|
Record UNII |
B83N349DUW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9840534
Created by
admin on Sat Dec 16 18:04:08 UTC 2023 , Edited by admin on Sat Dec 16 18:04:08 UTC 2023
|
PRIMARY | |||
|
149549-14-4
Created by
admin on Sat Dec 16 18:04:08 UTC 2023 , Edited by admin on Sat Dec 16 18:04:08 UTC 2023
|
PRIMARY | |||
|
DTXSID601212836
Created by
admin on Sat Dec 16 18:04:08 UTC 2023 , Edited by admin on Sat Dec 16 18:04:08 UTC 2023
|
PRIMARY | |||
|
B83N349DUW
Created by
admin on Sat Dec 16 18:04:08 UTC 2023 , Edited by admin on Sat Dec 16 18:04:08 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |